August 20th 2025, 1:00pm
CAR-T cell therapies are now being explored for the treatment of solid tumors like gliomas, Dr. Tanja A. Gruber explained in an interview with CURE.
August 19th 2025, 8:00pm
Personalized vaccines are currently being investigated for the treatment of patients with kidney cancer; however, the investigation is still in early stages.
August 19th 2025, 1:00pm
Although GIST can be identified during an endoscopy, according to Dr. Rosario Ligresti, these are still rare tumors that warrant further characterization.
August 18th 2025, 4:00pm
For patients undergoing a radical cystectomy, staying active before and after surgery is key, Dr. Janet Kukreja explained.
August 18th 2025, 1:00pm
Natural killer cells, also referred to as NK cells, play several major roles in the body's defense against cancers like renal cell carcinoma.
August 15th 2025, 8:00pm
It is important to expand clinical trial access for patients with kidney cancer in order to ensure a representative study population.
August 15th 2025, 1:00pm
The accelerated approval of Modeyso for diffuse midline glioma with an H3 K27M mutation, is a step in the right direction but more work remains.
August 14th 2025, 8:00pm
Dr. Jim Omel, who was diagnosed with multiple myeloma in 1997, explained how the treatment landscape has changed over nearly 30 years.
August 14th 2025, 1:00pm
There are many reliable resources available to patients with kidney cancer, as well as their families and caregivers.
August 13th 2025, 8:00pm
Follicular lymphoma survivor Troy Anderson credited acupuncture and nutrition guidance with easing treatment side effects and aided in remission.
Understanding Your Diagnosis: Stage 2 Oral Cavity Cancer
Understanding Your Diagnosis of Bile Duct Cancer
Understanding Your Stage 2 Uterine (Endometrial) Cancer
Top Blood Cancer Stories from October: Key Updates for Patients